Blisibimod
[4-methyl-5-[(2E,4E)-5-phenylpenta-2,4-dienoyl]-1,3-thiazol-2-yl]thiourea
Molecular Identity
Blisibimod
[4-methyl-5-[(2E,4E)-5-phenylpenta-2,4-dienoyl]-1,3-thiazol-2-yl]thiourea
PubChem CID: 51059404
2D Structure
Properties
C16H15N3OS2
Molecular Formula
329.40
Molecular Weight
g/mol
329.0657
Exact Mass
Da
3.6
XLogP
Drug-like (Lipinski: < 5)
128
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
4
H-Bond Acceptors
458
Complexity
SMILES
Canonical SMILES
SMILES: CC1=C(SC(=N1)NC(=S)N)C(=O)C=CC=CC2=CC=CC=C2Isomeric SMILES
SMILES: CC1=C(SC(=N1)NC(=S)N)C(=O)/C=C/C=C/C2=CC=CC=C2Synonyms(8)
blisibimodumBlisibimodRefChem:917385A-623114VP6C6ESAMG 623AMG-6231236126-45-6
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Blisibimod
Loading drug network...